Post-stroke dementia - a comprehensive review.
Mijajlović MD, Pavlović A, Brainin M, Heiss WD, Quinn TJ, Ihle-Hansen HB, Hermann DM, Assayag EB, Richard E, Thiel A, Kliper E, Shin YI, Kim YH, Choi S, Jung S, Lee YB, Sinanović O, Levine DA, Schlesinger I, Mead G, Milošević V, Leys D, Hagberg G, Ursin MH, Teuschl Y, Prokopenko S, Mozheyko E, Bezdenezhnykh A, Matz K, Aleksić V, Muresanu D, Korczyn AD, Bornstein NM.
Mijajlović MD, et al.
BMC Med. 2017 Jan 18;15(1):11. doi: 10.1186/s12916-017-0779-7.
BMC Med. 2017.
PMID: 28095900
Free PMC article.
Review.
Currently, no specific biomarkers have been proven to robustly discriminate vulnerable patients ('at risk brains') from those with better prognosis or to discriminate Alzheimer's disease dementia from PSD. ...As treatment strategies to inhibit the development and mi …
Currently, no specific biomarkers have been proven to robustly discriminate vulnerable patients ('at risk brains') from those with be …